Literature DB >> 11231969

Compound heterozygous mutations in the gamma subunit gene of ENaC (1627delG and 1570-1G-->A) in one sporadic Japanese patient with a systemic form of pseudohypoaldosteronism type 1.

M Adachi1, K Tachibana, Y Asakura, S Abe, J Nakae, T Tajima, K Fujieda.   

Abstract

The systemic form of pseudohypoaldosteronism type 1 (PHA1) is a rare autosomal recessive disorder with salt-wasting, hyperkalemia, metabolic acidosis, and multiorgan aldosterone unresponsiveness. Recently, this form of PHA1 was found to be caused by the loss-of-function mutations in the gene of each subunit (alpha, beta, and gamma) of the epithelial sodium channel (ENaC). To investigate the molecular basis of one sporadic Japanese patient with a systemic form of PHA1, we determined the nucleotide sequence of the genes of every subunit of ENaC of this patient. The patient was found to be a compound heterozygote for one base deletion in exon 12 (1627delG) in combination with 1570-1-->GA substitution at the 5' splice acceptor site of intron 11 in the gamma subunit gene of ENaC. The 1627delG mutation altered a reading frame, resulting in a premature stop codon in exon 12. Messenger RNA from the allele harboring the splice site mutation was not identified by RT-PCR. In conclusion, two novel mutations in the gamma subunit gene of ENaC caused systemic PHA1 in the sporadic Japanese patient. Identification of the molecular basis of PHA1 is helpful for early diagnosis and understanding the pathophysiology of the disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11231969     DOI: 10.1210/jcem.86.1.7116

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  Epithelial Na+ channel subunit stoichiometry.

Authors:  Alexander Staruschenko; Emily Adams; Rachell E Booth; James D Stockand
Journal:  Biophys J       Date:  2005-04-08       Impact factor: 4.033

2.  Deletion of α-subunit exon 11 of the epithelial Na+ channel reveals a regulatory module.

Authors:  Jingxin Chen; Thomas R Kleyman; Shaohu Sheng
Journal:  Am J Physiol Renal Physiol       Date:  2014-01-08

3.  Increased Na reabsorption via the Na-Cl cotransporter in autosomal recessive pseudohypoaldosteronism.

Authors:  Masanori Adachi; Yumi Asakura; Koji Muroya; Toshihiro Tajima; Kenji Fujieda; Emiko Kuribayashi; Shunya Uchida
Journal:  Clin Exp Nephrol       Date:  2010-04-08       Impact factor: 2.801

4.  Af17 deficiency increases sodium excretion and decreases blood pressure.

Authors:  Lihe Chen; Hongyu Wu; Oleh M Pochynyuk; Mary Rose Reisenauer; Zhijing Zhang; Le Huang; Oleg Leonidovych Zaika; Mykola Mamenko; Weiru Zhang; Qiaoling Zhou; Mingyao Liu; Yang Xia; Wenzheng Zhang
Journal:  J Am Soc Nephrol       Date:  2011-05-05       Impact factor: 10.121

Review 5.  Dietary potassium restriction attenuates urinary sodium wasting in the generalized form of pseudohypoaldosteronism type 1.

Authors:  Masanori Adachi; Toshihiro Tajima; Koji Muroya
Journal:  CEN Case Rep       Date:  2020-01-03

Review 6.  The interplay of renal potassium and sodium handling in blood pressure regulation: critical role of the WNK-SPAK-NCC pathway.

Authors:  Aihua Wu; Martin Wolley; Michael Stowasser
Journal:  J Hum Hypertens       Date:  2019-02-05       Impact factor: 3.012

7.  Clinical features and molecular basis of pseudohypoaldosteronism type 1.

Authors:  Toshihiro Tajima; Shuntaro Morikawa; Akie Nakamura
Journal:  Clin Pediatr Endocrinol       Date:  2017-07-27

8.  Restoration of Epithelial Sodium Channel Function by Synthetic Peptides in Pseudohypoaldosteronism Type 1B Mutants.

Authors:  Anita Willam; Mohammed Aufy; Susan Tzotzos; Heinrich Evanzin; Sabine Chytracek; Sabrina Geppert; Bernhard Fischer; Hendrik Fischer; Helmut Pietschmann; Istvan Czikora; Rudolf Lucas; Rosa Lemmens-Gruber; Waheed Shabbir
Journal:  Front Pharmacol       Date:  2017-02-24       Impact factor: 5.988

9.  Systemic pseudohypoaldosteronism-1 with episodic dyslipidemia in a Sudanese child.

Authors:  Asmahan Abdalla; Mohammed Abdulrahman Alhassan; Reem Tawfeeg; Ayman Sanad; Hasan Tawamie; Mohamed Abdullah
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2021-06-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.